Protara Therapeutics (TARA) Short-Term Debt issuances (2020)

Protara Therapeutics (TARA) recorded quarterly Short-Term Debt issuances of -$557000.0 in Q3 2020, down 50.13% quarter-over-quarter from -$371000.0 in Q2 2020.

Protara Therapeutics (TARA) Short-Term Debt issuances (2020) Analysis & Trends

Protara Therapeutics' Short-Term Debt issuances history runs 1 years deep, the most recent figure standing at -$557000.0 for Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -33,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Protara Therapeutics 216.35 Mn 216.35 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 -557,000.00
Sep 30, 2020 -557,000.00
Jun 30, 2020 -371,000.00
Jun 30, 2020 -371,000.00
Mar 31, 2020 -370,000.00
Mar 31, 2020 -370,000.00